切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (05) : 414 -416. doi: 10.3877/cma.j.issn.2095-3224.2017.05.013

所属专题: 文献

综述

直肠肛管恶性黑色素瘤的临床特点及诊疗进展
袁子茗1, 王锡山2,()   
  1. 1. 150086 哈尔滨医科大学附属第二医院结直肠肿瘤外科
    2. 100021 北京,国家癌症中心/中国医学科学院北京协和医学院肿瘤医院结直肠外科
  • 收稿日期:2017-01-04 出版日期:2017-10-25
  • 通信作者: 王锡山
  • 基金资助:
    国家自然科学基金面上项目(No.81572930); 中国医学科学院肿瘤医院学科带头人奖励基金(No.RC2016003); 国家重点研发计划精准医学研究专项(No.2016YFC0905300); 中国医学科学院医学与健康科技创新工程项目(No.2016-I2M-1-001)

Diagnosis and treatment progress and clinical characteristics of anorectal malignant melanoma

Ziming Yuan1, Xishan Wang2,()   

  1. 1. Department of Colorectal Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China
    2. Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2017-01-04 Published:2017-10-25
  • Corresponding author: Xishan Wang
  • About author:
    Corresponding author: Wang Xishan, Email:
引用本文:

袁子茗, 王锡山. 直肠肛管恶性黑色素瘤的临床特点及诊疗进展[J]. 中华结直肠疾病电子杂志, 2017, 06(05): 414-416.

Ziming Yuan, Xishan Wang. Diagnosis and treatment progress and clinical characteristics of anorectal malignant melanoma[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(05): 414-416.

直肠肛管恶性黑色素瘤(ARMM)是一种相当罕见,具备侵袭性且预后差的消化道恶性肿瘤,其发生率占肛门直肠恶性肿瘤的0.05~4.6%,因该病缺乏典型的临床特点,与消化道常见肿瘤不易区分,故容易误诊,且预后较差,复发率高,现阶段仍以手术治疗为主要手段,本篇文章通过结合相关文献及治疗指南,对该病的病理生理学特点、临床特点及诊疗进展进行分析总结,以对临床治疗有所贡献。

Anorectal malignant melanoma (ARMM) is a very rare digestive tract malignancy which is of high invasiveness and poor prognosis. It accounts for 0.05~4.6% of anorectal cancer. As ARMM lacks typical manifestation and is difficult to differentiate from other common digestive malignancies, it is difficult to make a correct diagnosis. ARMM has a poor prognosis and high recurrence rate. Surgery is still the main modality. In this paper, we analyzed and summarized the pathophysiology, clinical characteristics, and diagnosis and treatment progress by referring to the relevant literature and treatment guidelines. We hope to contribute to clinical treatment.

[1]
Falch C, Stojadinovic A, Hann-von-Weyhern C, et al. Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification[J]. J Am Coll Surg, 2013, 217(2):324-335.
[2]
Ishizone S, Koide N, Karasawa F, et al. Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese cases[J]. Int J Colorectal Dis, 2008, 23(12):1257-1262.
[3]
Thibault C, Sagar P, Nivatvongs S, et al. Anorectal melanoma--an incurable disease ?[J]. Dis Colon Rectum, 1997, 40:661-668.
[4]
Ma MS, Kim CY, Kim JA. Anorectal malignant melanoma: a case report[J]. J Korean Surg Soc, 1997, 52:458-464.
[5]
王锡山.肛管直肠恶性黑色素瘤诊治指南解读[J]. 中华结直肠疾病电子杂志, 2015, 4(2):132-134.
[6]
Ghittoni R, Accardi R, Chiocca S, et al. Role of human papillomaviruses in carcinogenesis[J]. Ecancermedicalscience, 2015, (9):526.
[7]
李鹏,钟进,刘筠, 等.不典型肛管直肠恶性黑色素瘤诊断并文献复习[J]. 国际医学放射学杂志, 2016, 39(2):175-178.
[8]
Podnos YD, Tsai NC, Smith D, et al. Factors affecting survival in patients with anal melanoma[J]. Am Surg, 2006, 72(10):917-920.
[9]
Stoidis CN, Spyropoulos BG, Misiakos EP, et al. Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report[J]. World J Surg Oncol, 2009, (7):64.
[10]
Aytac B, Adim SB, Yerci O, et al. Anorectal malignant melanomas: experience of Uludag University[J]. Kaohsiung J Med Sci, 2010, 26(12):658-662.
[11]
Meguerditchian AN, Meterissian SH, Dunn KB. Anorectal melanoma: diagnosis and treatment[J]. Dis Colon Rectum, 2011, 54(5):638-644.
[12]
Del Grande F, Santini F, Herzka DA, et al. Fat-suppression techniques for 3-T MR imaging of the musculoskeletal system[J]. Radiographics, 2014, 34(1):217-233.
[13]
Kelly P, Zagars GK, Cormier JN, et al. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience[J]. Cancer, 2011, 117(20):4747-4755.
[14]
Jake S. O′Donnell, Georgina V. Long d, Richard A. Scolyer e, et al. Resistance to PD1/PDL1 checkpoint inhibition[J]. Cancer Treatment Reviews, 2017, (52):71–81.
[15]
Anne R. Bresnick, David J. Weber, and Danna B. Zimmer. S100 proteins in cancer[J]. Nat Rev Cancer, 2015, 15(2):96–109.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[3] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[4] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[5] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[6] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[7] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[8] 王亮, 符谨诚, 许薇, 李彦庆, 郭永波, 邹科见. 直肠成熟囊性畸胎瘤伴直肠阴道瘘一例并文献复习[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 117-118.
[9] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[10] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[11] 郑秀丽, 倪敏. 功能性便秘患者的直肠肛门抑制反射特征分析100例[J]. 中华临床医师杂志(电子版), 2023, 17(08): 870-875.
[12] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[13] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[14] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[15] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
阅读次数
全文


摘要